GlassScriptPhysician profile
Jennifer B Scheer
NPI 1700317476
$1,094.74
in general payments reported to CMS, 2019-2025
14 companies · $359 in 2025
The $359 reported for 2025 was more than what 88% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.88 · 2023: $140 · 2024: $582 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,080.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $356.13 | 2023-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $227.40 | 2023-2025 | Qelbree, Qelbree |
| Sanofi-Aventis U.S. LLC | $108.55 | 2024-2025 | |
| Ironshore Pharmaceuticals INC. | $106.25 | 2023-2024 | Jornay Pm |
| Collegium Pharmaceutical, INC. | $70.66 | 2025 | Jornay Pm |
| Tris Pharma INC | $63.74 | 2023-2025 | Dyanavel Xr |
| Merck Sharp & Dohme LLC | $44.36 | 2024 | Gardasil, Gardasil 9, Vaxelis |
| Exact Sciences Corporation | $25.34 | 2025 | The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $18.38 | 2025 | Wegovy |
| Pfizer INC. | $17.18 | 2025 | |
| Vertical Pharmaceuticals, LLC | $15.73 | 2025 | Relexxii |
| Glaxosmithkline, LLC. | $13.88 | 2025 | Bexsero |
| Kaleo, INC. | $13.88 | 2022 | |
| Sanofi Pasteur INC. | $13.26 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Scheer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.